1. Home
  2. CLDT vs ALT Comparison

CLDT vs ALT Comparison

Compare CLDT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDT
  • ALT
  • Stock Information
  • Founded
  • CLDT 2009
  • ALT 1997
  • Country
  • CLDT United States
  • ALT United States
  • Employees
  • CLDT N/A
  • ALT N/A
  • Industry
  • CLDT Real Estate Investment Trusts
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLDT Real Estate
  • ALT Health Care
  • Exchange
  • CLDT Nasdaq
  • ALT Nasdaq
  • Market Cap
  • CLDT 374.7M
  • ALT 292.0M
  • IPO Year
  • CLDT 2010
  • ALT N/A
  • Fundamental
  • Price
  • CLDT $7.61
  • ALT $3.83
  • Analyst Decision
  • CLDT Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • CLDT 2
  • ALT 6
  • Target Price
  • CLDT $10.75
  • ALT $17.40
  • AVG Volume (30 Days)
  • CLDT 264.3K
  • ALT 3.0M
  • Earning Date
  • CLDT 08-06-2025
  • ALT 08-12-2025
  • Dividend Yield
  • CLDT 4.72%
  • ALT N/A
  • EPS Growth
  • CLDT N/A
  • ALT N/A
  • EPS
  • CLDT 0.03
  • ALT N/A
  • Revenue
  • CLDT $310,140,000.00
  • ALT $20,000.00
  • Revenue This Year
  • CLDT N/A
  • ALT N/A
  • Revenue Next Year
  • CLDT $0.45
  • ALT $761,880.20
  • P/E Ratio
  • CLDT $277.86
  • ALT N/A
  • Revenue Growth
  • CLDT N/A
  • ALT N/A
  • 52 Week Low
  • CLDT $5.83
  • ALT $2.90
  • 52 Week High
  • CLDT $10.00
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • CLDT 63.27
  • ALT 51.79
  • Support Level
  • CLDT $7.57
  • ALT $3.35
  • Resistance Level
  • CLDT $7.82
  • ALT $3.66
  • Average True Range (ATR)
  • CLDT 0.16
  • ALT 0.19
  • MACD
  • CLDT 0.06
  • ALT 0.07
  • Stochastic Oscillator
  • CLDT 76.92
  • ALT 86.18

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: